EFAVIRENZ
Generic: EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Teva Pharmaceuticals USAManufacturer
ORALRoute
EFAVIRENZActive Substance
2018-11-09Original Approval
EFAVIRENZ is FDA application ANDA091215, sponsored by TEVA PHARMS USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FOETAL EXPOSURE DURING PREGNANCY
758 reports
2
PATHOGEN RESISTANCE
750 reports
3
VIROLOGIC FAILURE
749 reports
4
VIRAL MUTATION IDENTIFIED
706 reports
5
DRUG RESISTANCE
501 reports
6
DRUG INEFFECTIVE
438 reports
7
MATERNAL EXPOSURE DURING PREGNANCY
409 reports
8
DRUG INTERACTION
353 reports
9
TREATMENT FAILURE
301 reports
10
ABORTION SPONTANEOUS
285 reports